Odyssean LLC’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Other funds holding RARE
Odyssean LLC's RARE Position: Q3 2026 in Review
Odyssean LLC sold out of Ultragenyx Pharmaceutical (RARE) in Q3 2026, closing a stake of 122,087 shares — an estimated $4.08M sold.
Odyssean LLC first reported a position in RARE in Q4 2025 and held it in 3 quarters. The position peaked at $4.08M in Q2 2026. 268 funds tracked by Wall St. Rank hold RARE as of Q3 2026.
- Odyssean LLC reported no remaining Ultragenyx Pharmaceutical position as of Q3 2026 after selling out during the quarter.
- Odyssean LLC sold 122,087 Ultragenyx Pharmaceutical shares in Q3 2026, an estimated $4.08M.
- Odyssean LLC first reported a position in Ultragenyx Pharmaceutical in Q4 2025 and held it in 3 quarters.
- Odyssean LLC's Ultragenyx Pharmaceutical position peaked at $4.08M in Q2 2026.
- 268 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2026.
Based on Odyssean LLC's 13F filing for Q3 2026, filed 16 Nov 2026.